The Latest in Rheumatology

Too few RA patients get timely adjustment of DMARDs

October 3, 2017

Rheumatology

Launch of adalimumab biosimilar Amjevita postponed

September 29, 2017

ACP osteoporosis treatment guideline debated

September 28, 2017

Immunogenicity concerns for biosimilars so far don’t go beyond originator biologics

September 27, 2017

Rheumatology

Early ankylosing spondylitis treatment stops transition from inflammatory to bone-forming fatty lesions

September 27, 2017

Rheumatology

ECHO rheumatology programs increase access, improve care

September 27, 2017

Romosozumab reduces fracture risk out to 36 months, with no signs of cardiovascular problems

September 26, 2017

‘Multimorbidities’ in RA make impact on treatment efficacy, disease activity

September 26, 2017

Rheumatology

Teriparatide reduces fractures over risedronate in all subgroups with osteoporosis

September 22, 2017

Preferred osteoporosis treatment order with teriparatide, denosumab reaffirmed

September 21, 2017

Survival in lupus patients has plateaued

September 21, 2017

Rheumatology

Ultrasound’s value for arthralgia may be to rule out IA

September 20, 2017

Incidental hip CT scans could serve as osteoporosis screen

September 12, 2017

Lack of lupus ‘gold standard’ definition hampers estimates of its incidence, prevalence

September 12, 2017

Rheumatology

CREST syndrome and PBC are often associated

September 11, 2017